NCT00288548

Metoprolol and Formoterol in Chronic Obstructive Pulmonary Disease (COPD)

Pulmonary Effects of the Combination of Metoprolol and Formoterol in COPD

• Status: Unknown
• Phase: Phase 4
• Study type: Interventional
• Enrollment: 45 (planned)
• Sponsor: Martini Hospital Groningen · Academic / Other
• Sex: All
• Age: 40 Years – 70 Years
• Healthy volunteers: Accepted

Summary

We want to study the effect of the combination of metoprolol (a beta-blocker) with formoterol (a beta-agonist) on long function in patients with Chronic Obstructive Pulmonary Disease (COPD). There are more and more clues that a beta-blocker, when well chosen and in the right dosage, won't harm the long function in patients with COPD. Since a beta-blocker can be a valuable addition to treating patients with heart problems we would like to see if this category of medication can be available for COPD patients in the future.

Conditions

• Chronic Obstructive Pulmonary Disease (COPD)

Interventions

Type	Name	Description
DRUG	Metoprolol

Timeline

• Start date: 2006-02-01
• First posted: 2006-02-08
• Last updated: 2006-02-20

Locations

1 site across 1 country: Netherlands